Fluorescent Ligands for Dopamine D/D Receptors
Authors
Affiliations
Fluorescent ligands are versatile tools for the study of G protein-coupled receptors. Depending on the fluorophore, they can be used for a range of different applications, including fluorescence microscopy and bioluminescence or fluorescence resonance energy transfer (BRET or FRET) assays. Starting from phenylpiperazines and indanylamines, privileged scaffolds for dopamine D-like receptors, we developed dansyl-labeled fluorescent ligands that are well accommodated in the binding pockets of D and D receptors. These receptors are the target proteins for the therapy for several neurologic and psychiatric disorders, including Parkinson's disease and schizophrenia. The dansyl-labeled ligands exhibit binding affinities up to 0.44 nM and 0.29 nM at DR and DR, respectively. When the dansyl label was exchanged for sterically more demanding xanthene or cyanine dyes, fluorescent ligands 10a-c retained excellent binding properties and, as expected from their indanylamine pharmacophore, acted as agonists at DR. While the Cy3B-labeled ligand 10b was used to visualize DR and DR on the surface of living cells by total internal reflection microscopy, ligand 10a comprising a rhodamine label showed excellent properties in a NanoBRET binding assay at DR.
A bitter anti-inflammatory drug binds at two distinct sites of a human bitter taste GPCR.
Peri L, Matzov D, Huxley D, Rainish A, Fierro F, Sapir L Nat Commun. 2024; 15(1):9991.
PMID: 39557861 PMC: 11574016. DOI: 10.1038/s41467-024-54157-6.
Vogt H, Shinkwin P, Huber M, Staffen N, Hubner H, Gmeiner P ACS Pharmacol Transl Sci. 2024; 7(5):1533-1545.
PMID: 38751637 PMC: 11092115. DOI: 10.1021/acsptsci.4c00086.
Optical Control of Dopamine D2-like Receptors with Cell-Specific Fast-Relaxing Photoswitches.
Hetzler B, Donthamsetti P, Peitsinis Z, Stanley C, Trauner D, Isacoff E J Am Chem Soc. 2023; 145(34):18778-18788.
PMID: 37586061 PMC: 10472511. DOI: 10.1021/jacs.3c02735.
Fluorescent Investigation of Proteins Using DNA-Synthetic Ligand Conjugates.
Winer L, Motiei L, Margulies D Bioconjug Chem. 2023; 34(9):1509-1522.
PMID: 37556353 PMC: 10515487. DOI: 10.1021/acs.bioconjchem.3c00203.
Huber M, Wurnig S, Toy L, Weiler C, Merten N, Kostenis E J Med Chem. 2023; 66(14):9916-9933.
PMID: 37463496 PMC: 10388362. DOI: 10.1021/acs.jmedchem.3c00769.